Soaanz patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10154963 SARFE PHARMS Controlled-release formulations comprising Torsemide
Oct, 2033

(9 years from now)

Soaanz is owned by Sarfe Pharms.

Soaanz contains Torsemide.

Soaanz has a total of 1 drug patent out of which 0 drug patents have expired.

Soaanz was authorised for market use on 14 June, 2021.

Soaanz is available in tablet;oral dosage forms.

The generics of Soaanz are possible to be released after 06 October, 2033.

Drugs and Companies using TORSEMIDE ingredient

Market Authorisation Date: 14 June, 2021

Treatment: NA


More Information on Dosage

SOAANZ family patents

Family Patents